Background

Professor Stoové is Head of Public Health at Burnet Institute where he also and heads research groups in HIV Prevention and Justice Health. He has undertaken research on the epidemiology and prevention of blood borne viruses and sexually transmitted infections and the health and wellbeing of affected populations for over 20 years. His research focuses is on generating evidence for effective public health policy and practice.

He has strong interests in developing novel and innovative approaches to epidemiological research to inform clinical and public health policy and practice He has led the development and maintenance of innovative sentinel surveillance systems for HIV and other sexually transmitted infections and blood borne viruses in developed and low and middle income countries.

He has also led large bio-behavioural prospective cohort studies of people who inject drugs and other groups disproportionately affected by viral hepatitis, HIV and other sexually transmitted infections. I has helped lead large-scale sexual health and sexually transmitted infection prevention program implementations and randomised controlled trials in Australia and low income settings internationally.

He has published over 200 peer reviewed paper and assumes various editorial roles for international peer review journal editorial roles as well as conference convening roles. Over the past five years he has attracted in excess of AUD$30 million in research funds as a lead investigator.

Positions

• 2017: Co-Head, Eliminate HIV sub-Program, Disease Elimination Program, Burnet Institute
• 2012: Head, HIV Research; Head, Justice Health Research, Burnet Institute
• 2017: Head of Public Health Discipline, Burnet Institute
• 2011: Principal for Sexual and Reproductive Health, Burnet Institute
• 2007-2012: Senior Research Fellow / Head of HIV/STI Research - Centre for Population Health, Burnet Institute, Victoria, Australia
• 2007-present: Honorary Research Fellow - School of Psychology, Deakin University, Victoria, Australia
• 2008-present: Adjunct Research Fellow – Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia

Qualifications

• 2004: PhD, Victoria University, Melbourne, Australia.
• 1999: Grad Dip (Ed) RMIT, Melbourne, Australia
• 1995: BA AppSci (Hons, First Class), Victoria University, Melbourne, Australia.

Projects (47)

Current (25)

• 

  ACCESS: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood Borne Viruses and Sexually Transmitted Infections

• 

  Ageing Well with HIV

• 

  Assessing the feasibility of an integrated HIV cascade of care surveillance system in Myanmar (ACCESS Myanmar)

• 

  Blood-borne virus and STI self-testing❗Student Projects Available

• 

  Breaking the cycle: supporting people with drug use histories to avoid reincarceration

• 

  Cancer information compared to Hepatitis B information to INcreAse hepatitis B testing in Melbourne’s Chinese community (CHINA-B study)

• 

  Community-Based Rapid HIV Testing Services

• 

  COVASIM: Modelling COVID-19

• 

  EC Australia: Eliminate Hepatitis C Australia Partnership

• 

  EC Partnership: Eliminate Hepatitis C Partnership

• 

  Evaluation of Malaria Case-Based Reporting using a mobile phone application in Myanmar

• 

  HIV Prevention Cohort

• 

  Improving Hepatitis B Virus screening in general practice in Victoria

• 

  Novel PoC Testing for Diagnosis of Active Syphilis in Pregnant Women and Infants in Fiji

• 

  PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)

• 

  Project Geldom

• 

  PRONTO! Rapid HIV point-of-care testing in Victoria

• 

  Sexual health and STIs among people who use drugs❗Student Projects Available

• 

  SHARP: Sexual Health And Risk Prevention Study

• 

  TAIPAN: HIV cascade surveillance

• 

  The elimination of hepatitis C as a global public health threat

• 

  The International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

• 

  The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19

• 

  The QuickStart Study

• 

  VOICE - Victorian Online Initiative for Community Engagement

Past (2)

• 

  co-EC Study: Eliminating hepatitis C/HIV coinfection

• 

  PATH Cohort Study

Publications (288)

2023 (18)

• Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis.
  Manoharan L, Latham NH, Munari SC, Traeger MW, Menon V, Luhmann N, Baggaley R, Macdonald V, Verster A, Siegfried N, Matthews GV, Stoové M, Hellard ME, Doyle JS
  Hepatol Commun. 2023 Apr; 7(4)
• Assessment of a primary care e-support package of automated case finding, simplified treatment algorithm and decision support to increase hepatitis B treatment uptake in primary care clinics in Australia (SIMPLY-B Study): protocol for a pilot evaluation.
  Moussa D, Wallace J, Manski-Nankervis JA, Doyle JS, Nguyen L, Boyle D, Stoové MA, Asselin J, Valaydon Z, Ahad M, Glasgow S, New K, Hocking JS, Sanci L, Thompson A, Hellard M, Howell J
  BMJ Open. 2023 Mar; 13(3):e070663
• Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.
  MacIsaac MB, Whitton B, Hubble A, Cogger S, Penn M, Weeks A, Elmore K, Pemberton D, Anderson J, Howard R, McKeever U, Papaluca T, Hellard ME, Stoové M, Wilson D, Pedrana A, Doyle J, Clark N, Holmes J, Thompson AJ
  Med J Aust. 2023 Mar; Epub ahead of print
• The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.
  Rathnayake K, Agius PA, Ward B, Hickman M, Maher L, Stoové M, Doyle JS, Hellard M, Wilkinson A, Quinn B, Crawford S, Sutton K, Dietze P
  Addiction. 2023 Mar; Epub ahead of print
• Consensus recommendations on the management of hepatitis C in Australia's prisons.
  Winter RJ, Sheehan Y, Papaluca T, Macdonald GA, Rowland J, Colman A, Stoové M, Lloyd AR, Thompson AJ
  Med J Aust. 2023 Mar; 218(5):231-237
• The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea: a pragmatic, cluster-randomised, stepped-wedge, open-label trial.
  Mohamed Y, Htay H, Gare J, Vallely AJB, Kelly-Hanku A, Yee WL, Agius PA, Badman SG, Pham MD, Nightingale C, Chen XS, Kombati Z, Koata A, Munnull G, Silim S, Thein W, Zaw TM, Kyaw LL, Stoové M, Crowe SM, Anderson D, Tin HH, Luchters S
  Lancet HIV. 2023 Mar; Epub ahead of print
• Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011-2019.
  Carter A, McManus H, Ward JS, Vickers T, Asselin J, Baillie G, Chow EP, Chen MY, Fairley CK, Bourne C, McNulty A, Read P, Heath K, Ryder N, McCloskey J, Carmody C, McCormack H, Alexander K, Casey D, Stoove M, Hellard ME, Donovan B, Guy RJ.
  Med J Aust. 2023 Feb; 218(5):223-228
• Recruiting and retaining community-based participants in a COVID-19 longitudinal cohort and social networks study: lessons from Victoria, Australia.
  Nguyen T, Thomas AJ, Kerr P, Stewart AC, Wilkinson AL, Nguyen L, Altermatt A, Young K, Heath K, Bowring A, Fletcher-Lartey S, Lusher D, Hill S, Pedrana A, Stoové M, Gibney K, Hellard M
  BMC Med Res Methodol. 2023 Feb; 23(1):54
• Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study.
  Heron JE, McManus H, Vickers T, Ryan K, Wright E, Carter A, Stoove M, Asselin J, Grulich A, Donovan B, Guy R, Varma R, Chen M, Ryder N, Lewis DA, Templeton DJ, O'Connor CC, Gracey DM; ACCESS Collaboration
  PLoS One. 2023 Feb; 18(2):e0280339
• Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia.
  Curtis M, Wilkinson AL, Dietze P, Stewart AC, Kinner SA, Cossar RD, Nehme E, Aitken C, Walker S, Butler T, Winter RJ, Smith K, Stoové M
  Emerg Med J. 2023 Feb; Epub ahead of print
• Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019.
  van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group.
  EClinicalMedicine. 2023 Feb; 56:101810
• Inclusion of Cultural and Linguistic Diversity in COVID-19 Public Health Research: Research Design Adaptations to Seek Different Perspectives in Victoria, Australia.
  Gibbs L, Thomas AJ, Coelho A, Al-Qassas A, Block K, Meagher N, Eisa L, Fletcher-Lartey S, Ke T, Kerr P, Kwong EJL, MacDougall C, Malith D, Marinkovic Chavez K, Osborne D, Price DJ, Shearer F, Stoové M, Young K, Zhang Y, Gibney KB, Hellard M
  Int J Environ Res Public Health. 2023 Jan; 20(3):2320
• Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia.
  Altermatt A, Heath K, Saich F, Wilkinson AL, Scott N, Sacks-Davis R, Young K, Stoové M, Gibney KB, Hellard M
  Aust N Z J Public Health. 2023 Jan; 47(1):100007
• The prevalence of drug driving and being caught for a drug driving offense among community-recruited people who use methamphetamine in metropolitan and rural Victoria, Australia.
  Nightingale C, Kippen R, Ward B, Stoové M, Quinn B, Sutton K, Dietze P
  Traffic Inj Prev. 2023 Jan; 24(2):103-108
• Trust and service engagement among people who inject drugs after release from prison.
  Lafferty L, Schroeder S, Marshall AD, Drysdale K, Higgs P, Stoové M, Baldry E, Dietze P, Treloar C
  Int J Drug Policy. 2023 Jan; 111:103925
• Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis.
  Curtis M, Dietze P, Wilkinson AL, Agius PA, Stewart AC, Cossar RD, Butler T, Walker S, Kirwan A, Winter RJ, Stoové M
  Drug Alcohol Depend. 2023 Jan; 242:109730
• Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta-analysis.
  Nevendorff L, Schroeder SE, Pedrana A, Bourne A, Stoové M
  J Int AIDS Soc. 2023 Jan; 26(1):e26054
• Non-fatal opioid overdose after release from prison among men who injected drugs prior to their imprisonment: a prospective data linkage study.
  Curtis M, Dietze P, Winter RJ, Rathnayake K, Smith K, Stoové M
  Med J Aust. 2023 Jan; 218(3):94-95

2022 (38)

• Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.
  Wallace J, Richmond J, Howell J, Hajarizadeh B, Power J, Treloar C, Revill PA, Cowie B, Wang S, Stoové M, Pedrana A, Hellard M
  Viruses. 2022 Nov; 14(11):2542
• Assessment of the lifetime prevalence and incidence of induced abortion and correlates among female sex workers in Mombasa, Kenya: a secondary cohort analysis.
  Simmelink AM, Gichuki CM, Ampt FH, Manguro G, Lim MSC, Agius P, Hellard M, Jaoko W, Stoové MA, L'Engle K, Temmerman M, Gichangi P, Luchters S
  BMJ Open. 2022 Oct; 12(10):e053218
• Reflections on the in-prison recruitment and participation of men with a history of injecting drug use, in a longitudinal cohort study in Australia.
  Walker S, Curtis M, Woods E, Pierce L, Kirwan A, Stewart AC, Cossar R, Winter R, Dietze P, Kinner SA, Ogloff JRP, Butler T, Stoové M
  J Criminol. 2022 Sep; 55(4):586-603
• The Optimise Study: COVID-19 vaccine intention, and adherence to isolation and quarantine recommendations. (PUBLIC HEALTH REPORT)
  Jin D, Saich F, Heath K, Altermatt A, Wilkinson A, Merner B, Ryan R, Pedrana A, Stoové M, Gibney K, Hellard M
  Burnet Institute Optimise Study. 2022 Sep; Report 17(Sep):1-15
• Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study.
  Papaluca T, Craigie A, McDonald L, Edwards A, Winter R, Hoang A, Pappas A, Waldron A, McCoy K, Stoové M, Doyle J, Hellard M, Holmes J, MacIsaac M, Desmond P, Iser D, Thompson AJ
  Open Forum Infect Dis. 2022 Aug; 9(8):ofac350
• Why risk matters for STI control: who are those at greatest risk and how are they identified?
  Traeger M, Stoové M
  Sex Health. 2022 Aug; 19(4):265-277
• The Optimise Study: COVID-19 related worry, acceptability of prevention measures and confidence in Government. (PUBLIC HEALTH REPORT)
  Jin D, Saich F, Heath K, Altermatt A, Merner B, Ryan R, Lusher D, Wang P, Pedrana A, Stoové M, Gibney K, Hellard M
  Optimise Study. 2022 Aug; Report 16(Aug):1-15
• The Optimise Study: A rapid survey examining frequency, impacts of long COVID and associated concerns. (PUBLIC HEALTH REPORT)
  Hellard M, Gibney K, Stoové M, Chavez KM, Wilkinson A, Heath K, Altermatt A, Young K, Nguyen T, Gibbs L, Osborne D, Jin D, Saich F
  Optimise Study. 2022 Aug; Special Report(Aug):1-13
• Constructing a 'target population': A critical analysis of public health discourse on substance use among gay and bisexual men, 2000-2020.
  Schroeder SE, Bourne A, Doyle JS, Hellard ME, Stoové M, Pedrana A
  Int J Drug Policy. 2022 Jul; 108:103808
• The acceptability and usability of two HIV self-test kits among men who have sex with men: a randomised crossover trial.
  Lee DY, Ong JJ, Smith K, Jamil MS, McIver R, Wigan R, Maddaford K, McNulty A, Kaldor JM, Fairley CK, Bavinton B, Chen M, Chow EP, Grulich AE, Holt M, Conway DP, Stoové M, Wand H, Guy RJ
  Med J Aust. 2022 Jul; 217(3):149-154
• Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward.
  Pham MD, Ong JJ, Anderson DA, Drummer HE, Stoové M
  Int J Environ Res Public Health. 2022 Jul; 19(13):8172
• The impact of COVID-19 on public health systems in the Pacific Island Countries and Territories.
  Bell L, van Gemert C, Merilles OE Jr, Cash HL, Stoové M, Hellard M
  Lancet Reg Health West Paci. 2022 Jun; 25(100498)
• Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs.
  Traeger MW, van Santen DK, Sacks-Davis R, Asselin J, Carter A, Doyle JS, Pedrana A, Wilkinson AL, Howell J, Thatcher R, Didlick J, Donovan B, Guy R, Hellard ME, Stoové MA; Australia Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS).
  J Viral Hepat. 2022 Jun; 29(10):908-918
• Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: A prospective observational study.
  Hill PL, Stoové M, Agius PA, Maher L, Hickman M, Crawford S, Dietze P.
  Addiction. 2022 Jun; 117(12):3091-3098
• High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment.
  Curtis M, Winter RJ, Dietze P, Wilkinson AL, Cossar RD, Stewart AC, Agius PA, Butler T, Aitken C, Kirwan A, Walker S, Stoové M
  Addiction. 2022 Jun; 117(11):2887-2898
• Latent Class Analysis of Sexual Behaviours and Attitudes to Sexually Transmitted Infections Among Gay and Bisexual Men Using PrEP.
  Traeger MW, Murphy D, Ryan KE, Asselin J, Cornelisse VJ, Wilkinson AL, Hellard ME, Wright EJ, Stoové MA
  AIDS Behav. 2022 Jun; 26(6):1808-1820
• The Optimise Study: A rapid survey examining the influence of potential cessation of the Victorian pandemic declaration. (PUBLIC HEALTH REPORT)
  Hellard M, Gibney K, Stoové M, Wilkinson A, Heath K, Altermatt A, Young K, Nguyen T, Jin D, Saich F
  Optimise Study. 2022 Jun; Special Report(Jun):1-10
• Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
  Traeger MW, Guy R, Asselin J, Patel P, Carter A, Wright EJ, Grulich A, McManus H, Fairley CK, Chow EPF, McNulty A, Finlayson R, Bell C, Owen L, Marshall L, Russell D, O'Donnell D, Donovan B, Hellard ME, Stoové MA; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS) Study Group.
  Lancet Infect Dis. 2022 May; 22(8):1231-1241
• Criminal Justice Involvement after Release from Prison following Exposure to Community Mental Health Services among People Who Use Illicit Drugs and Have Mental Illness: a Systematic Review.
  Stewart AC, Cossar RD, Quinn B, Dietze P, Romero L, Wilkinson AL, Stoové M
  J Urban Health. 2022 May; 99:635-654
• The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.
  Howell J, Traeger MW, Williams B, Layton C, Doyle JS, Latham N, Draper B, Bramwell F, Membrey D, McPherson M, Roney J, Stoové M, Thompson AJ, Hellard ME, Pedrana A
  J Viral Hepat. 2022 May; 29(5):375-384
• The Optimise Study: COVID-19 testing, test positivity and contacts over time. (PUBLIC HEALTH REPORT)
  Saich F, Jin D, Heath K, Altermatt A, Merner B, Wilkinson A, Hill S, Stoové M, Gibney K, Hellard M
  Optimise Study. 2022 May; Report 15(May):1-13
• Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020.
  Dawe J, Wilkinson AL, Asselin J, Carter A, Pedrana A, Traeger MW, Thomas AJ, Curtis M, Cooper M, Howell J, Doyle JS, Hellard ME, Stoové M; EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of blood borne viruses and sexually transmissible infections (ACCESS).
  Int J Drug Policy. 2022 Apr; 104:103696
• Preferences for HIV Testing Services and HIV Self-Testing Distribution Among Migrant Gay, Bisexual, and Other Men Who Have Sex With Men in Australia.
  Zhang Y, Wiseman V, Applegate TL, Lourenco RA, Street DJ, Smith K, Jamil MS, Terris-Prestholt F, Fairley CK, McNulty A, Hynes A, Johnson K, Chow EPF, Bavinton BR, Grulich A, Stoové M, Holt M, Kaldor J, Guy R, Ong JJ
  Front Med (Lausanne). 2022 Apr; 9:839479
• The Optimise Study: Summer 2021-2022 Snapshot. (PUBLIC HEALTH REPORT)
  Hellard M, Gibney K, Stoové M, Young K, Altermatt A, Heath K, Thomas A, Nguyen T, Wilkinson A, Merner B, Hill S, Saich F, Jin D
  Optimise Study. 2022 Apr; Special Report(Apr):1-20
• Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
  Marukutira T, Moore KP, Hellard M, Richmond J, Turner K, Pedrana AE, Melody S, Johnston FH, Owen L, Van Den Boom W, Scott N, Thompson A, Iser D, Spelman T, Veitch M, Stoové MA, Doyle J
  BMJ Open. 2022 Mar; 12(3):e056120
• Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020.
  Wilkinson AL, van Santen DK, Traeger MW, Sacks-Davis R, Asselin J, Scott N, Harney BL, Doyle JS, El-Hayek C, Howell J, Bramwell F, McManus H, Donovan B, Stoové M, Hellard M, Pedrana A
  Int J Drug Policy. 2022 Mar; 103:103655
• "It's not just the hit itself": the social practice of injecting drug use among gay and bisexual men in Australia.
  Schroeder SE, Bourne A, Doyle J, Stoove M, Hellard M, Pedrana A
  Int J Drug Policy. 2022 Mar; 103:103642
• Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study.
  Cossar RD, Stewart AC, Wilkinson AL, Dietze P, Ogloff JRP, Aitken C, Butler T, Kinner SA, Curtis M, Walker S, Kirwan A, Stoové M
  Int J Drug Policy. 2022 Mar; 101:103532
• A profile of the Visitect(R) CD4 and Visitect(R) CD4 advanced disease for management of people living with HIV.
  Pham MD, Stoove M, Crowe S, Luchters S, Anderson D`
  Expert Rev Mol Diagn. 2022 Mar; 22(3):247-252
• The Optimise Study: COVID-19 worry and perceptions about infection and potential severity. (PUBLiC HEALTH REPORT)
  Saich F, Tse WC, Heath K, Altermatt A, Merner B, Hill S, Jin D, Stoové M, Gibney K, Hellard M
  Optimise Study. 2022 Mar; Report 14(Mar):1-10
• Intent to Be Vaccinated against COVID-19 in Victoria, Australia.
  Heath K, Altermatt A, Saich F, Pedrana A, Fletcher-Lartey S, Bowring AL, Stoové M, Danchin M, Kaufman J, Gibney KB, Hellard M
  Vaccines (Basel). 2022 Jan; 10(2)
• "It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success.
  Schroeder SE, Drysdale K, Lafferty L, Baldry E, Marshall AD, Higgs P, Dietze P, Stoové M, Treloar C
  Int J Drug Policy. 2022 Jan; 101:103571
• Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.
  Curtis M, Berk J, Larney S, Rich JD, Stoové M
  Int J Drug Policy. 2022 Jan; 100:103572
• Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
  O'Keefe D, Gunn J, Ryan K, Djordjevic F, Kerr P, Gold J, Elsum I, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana AE
  BMJ Open. 2022 Jan; 12(1):e057618
• Assessment of the cost-effectiveness of Australia’s risksharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study.
  Scott N, Palmer A, Tidhar T, Stoové M, Sacks-Davis R, Doyle JS, Pedrana A, Thompson AJ, Wilson DP, Hellard M
  Lancet Reg Health - West Pac. 2022 Jan; 18:100316
• The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019.
  Harney BL, Sacks-Davis R, van Santen DK, Traeger M, Wilkinson AL, Asselin J, El-Hayek C, Fairley CK, Roth N, Bloch M, Matthews G, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS).
  Clin Infect Dis. 2022 Jan; 74(10):1804-1811
• Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX).
  Van Den Boom W, Quiroga MDM, O'Keefe D, Kumar D, Hill PL, Scott N, Agius PA, Higgs P, Kerr T, Maher L, Hickman M, Stoové M, Dietze P
  Int J Epidemiol. 2022 Jan; 51(3):e123-e130
• Psychiatric well-being among men leaving prison reporting a history of injecting drug use: A longitudinal analysis.
  Stewart AC, Cossar R, Wilkinson AL, Scott N, Dietze P, Quinn B, Kinner SA, Aitken C, Walker S, Curtis M, Butler T, Ogloff JRP, Stoové M
  Aust N Z J Psychiatry. 2022 Jan; 56(8):1034-1043

2021 (36)

• The Optimise Study:- Impacts of the COVID-19 response on culturally and linguistically diverse communities.(PUBLIC HEALTH REPORT)
  Saich F, Heath K, Altermatt A, Menon V, Munari S, Merner B, Hill S, Shearer F, Gibbs L, Coelho A, Fletcher-Lartey S, Stoové M, Gibney K, Hellard M
  Optimise Study. 2021 Dec; Report 13(Dec):1-12
• COVID-19 testing in schools and attitudes and concerns about the current state of the pandemic. (PUBLIC HEALTH REPORT)
  Saich F, Heath K, Altermatt A, Thomas A, Nguyen T, Wilinson A, Merner B, Hill S, Fletcher-Lartey S, Gibbs L, Gibbs L, Shearer F, Stoové M, Gibney K, Hellard M
  Optimise Study. 2021 Nov; Report 12(Nov):1-13
• Assessing the feasibility, acceptability and impacts of an education program on hepatitis B testing uptake among ethnic Chinese in Australia: results of a randomised controlled pilot study.
  Xiao Y, Wallace J, Ahad M, van Gemert C, Thompson AJ, Doyle J, Lam HY, Chan K, Bennett G, Adamson E, Yussf N, Tang A, Pedrana A, Stoove M, Hellard M, Howell J
  BMC Public Health. 2021 Oct; 21(1):1861
• COVID-19 testing and vaccination. (PUBLIC HEALTH REPORT)
  Saich F, Heath K, Altermatt A, Munari S, Merner B, Hill S, Stoové M, Gibney K, Hellard M
  Optimise Study. 2021 Oct; Report 11(Mar):1-11
• Tougher restrictions in NSW's 12 'LGAs of Concern' turns the corner on cases, not just rising vaccination levels. (PUBLIC HEALTH REPORT)
  Saul A, Crabb B, Stoové M
  Know-C19. 2021 Sep; September:1-6
• Strategies to maximise study retention and limit attrition bias in a prospective cohort study of men reporting a history of injecting drug use released from prison: the prison and transition health study.
  Stewart AC, Cossar R, Walker S, Wilkinson AL, Quinn B, Dietze P, Winter R, Kirwan A, Curtis M, Ogloff JRP, Kinner S, Aitken C, Butler T, Woods E, Stoové M
  BMC Med Res Methodol. 2021 Sep; 21(1):185
• Improvements in transition times through the HIV cascade of care among gay and bisexual men with a new HIV diagnosis in New South Wales and Victoria, Australia (2012-19): a longitudinal cohort study.
  van Santen DK, Asselin J, Haber NA, Traeger MW, Callander D, Donovan B, El-Hayek C, McMahon JH, Petoumenos K, McManus H, Hoy JF, Hellard M, Guy R, Stoové M; TAIPAN investigators.
  Lancet HIV. 2021 Sep; 8(10):e623-e632
• The Optimise Study: Information access and communication about COVID-19. (PUBLIC HEALTH REPORT)
  Saich F, Kwong E, Heath K, Altermatt A, Munari S, Merner B, Hill S, Stoové M, Wilson A, Caddy C, Lim M, Vogel J, Power R, Coghlan B, Cheong M, Bradfield Z, Homer C, Pedrana A, Gibney K, Hellard M
  Optimise Study. 2021 Sep; Report 10:1-13
• The Prison and Transition Health (PATH) cohort study: Prevalence of health, social, and crime characteristics after release from prison for men reporting a history of injecting drug use in Victoria, Australia.
  Stewart AC, Cossar RD, Wilkinson AL, Quinn B, Dietze P, Walker S, Butler T, Curtis M, Aitken C, Kirwan A, Winter R, Ogloff J, Kinner S, Stoové M
  Drug Alcohol Depend. 2021 Aug; 227:108970
• A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign.
  Palmer AY, Chan K, Gold J, Layton C, Elsum I, Hellard M, Stoove M, Doyle JS, Pedrana A, Scott N; EC Partnership
  J Viral Hepat. 2021 Aug; 28(11):1624-1634
• Routine testing for syphilis and other bacterial sexually transmissible infections is required among people in prison.
  Harney B, Doyle J, Hellard M, Stoové M, Winter R
  Sex Transm Dis. 2021 Aug; 48(10):e153
• The Optimise Study: Vaccination knowledge, attitudes and beliefs. (PUBLIC HEALTH REPORT)
  Saich F, Kwong E, Heath K, Altermatt A, Munari S. Merner B, Hill S, Stoové M, Griffiths D, Collie A, Lim M, Eddy S, Meagher N, McDougall C, Marinkovic Chavez K, Carpenter L, Fletcher-Lartey S, Price D, Gibbs L, Shearer F, Power R, Cheong M, Caddy C, Pedrana A, Gibney K, Hellard M
  Optimise Study. 2021 Aug; Report 9:1-15
• The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan city.
  Scott N, Saul A, Spelman T, Stoove M, Pedrana A, Saeri A, Grundy E, Smith L, Toole M, McIntyre CR, Crabb BS, Hellard M
  PLoS One. 2021 Jul; 16(7):e0253510
• The Optimise Study: Impact of government restrictions on risk mitigation strategies. (PUBLIC HEALTH REPORT)
  Saich F, Kwong E, Heath K, Altermatt A, Munari S. Merner B, Hill S, Power R, Cheong M, Caddy C, Griffiths D, Collie A, Stoové M, Pedrana A, Gibney K, Hellard M
  Optimise Study. 2021 Jul; Report 8:1-12
• Implications of HIV self-testing for other sexually transmissible infection testing and broader sexual health needs: a mixed methods study of gay and bisexual men in Australia.
  Leitinger D, Ryan K, Wilkinson AL, Pedrana A, Hellard M, Stoové M
  Sex Transm Dis. 2021 Jun; 48(6):417-423
• The Presence or Absence of Symptoms Among Cases of Urethral Gonorrhoea Occurring in a Cohort of Men Taking Human Immunodeficiency Virus Pre-exposure Prophylaxis in the PrEPX Study.
  Donovan LC, Fairley CK, Aung ET, Traeger MW, Wright EJ, Stoové MA, Chow EPF
  Open Forum Infect Dis. 2021 Jun; 8(6):ofab263
• The Optimise Study: The impact of COVID19 on income and finances. (PUBLIC HEALTH REPORT)
  Saich F, Kwong E, Heath K, Altermatt A, Munari S. Merner B, Hill S, Griffiths D, Collie A, Stoové M, Pedrana A, Gibney K, Hellard M
  Optimise Study. 2021 Jun; Report 7:1-9
• "It's time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C.
  Walker S, Wallace J, Latham N, Saich F, Pedrana A, Hellard M, Treloar C, Marukutira T, Higgs P, Doyle J, Stoové M
  Int J Drug Policy. 2021 May; 97:103280
• The Melbourne safe injecting room attracted people most in need of its service.
  Van Den Boom W, Del Mar Quiroga M, Fetene DM, Agius PA, Higgs PG, Maher L, Hickman M, Stoové MA, Dietze PM
  Am J Prev Me. 2021 May; 61(2):217-224
• Structural competency in the post-prison period for people who inject drugs: A qualitative case study.
  Treloar C, Schroeder S, Lafferty L, Marshall A, Drysdale K, Higgs P, Baldry E, Stoove M, Dietze P
  Int J Drug Policy. 2021 May; 95:103261
• Barriers and facilitators to pre-exposure prophylaxis among African migrants in high income countries: a systematic review.
  Mwaturura C, Traeger M, Lemoh C, Stoové M, Price B, Coelho A, Mikola M, Ryan KE, Wright E
  Sex Health. 2021 May; 18(2):130-139
• The Optimise Study: Gendered differences in coping and responding to COVID-19. (PUBLIC HEALTH REPORT)
  Saich F, Kwong E, Heath K, Altermatt A, Munari S. Merner B, Hill S, Stoové M, Pedrana A, Gibney K, Hellard M
  Optimise Study. 2021 May; Report 6:1-10
• Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs.
  Goutzamanis S, Spelman T, Harney B, Dietze P, Stoové M, Higgs P, Thompson A, Doyle JS, Hellard M; Treatment, Prevention Study group.
  J Viral Hepat. 2021 Apr; 28(7):1068-1077
• A new method for estimating the incidence of infectious diseases: Response to De Monte and Hudgens.
  McManus H, Guy RJ, Stoové MA
  Am J Epidemiol. 2021 Apr; 190(9):1969-1970
• A mobile phone application for malaria case-based reporting to advance malaria surveillance in Myanmar: a mixed methods evaluation.
  Oo WH, Htike W, Cutts JC, Win KM, Thu KM, Oo MC, Hkawng GN, Agius PA, Htoon PP, Scott N, Kearney E, Moreira C, Pedrana A, Stoove M, Thi A, Aung YW, Thein MM, Rosecrans K, Lwin KT, Min AK, Fowkes FJI
  Malar J. 2021 Mar; 20(1):167
• Low incidence of hepatitis C among a cohort of HIV-negative gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Melbourne, Australia, and the contribution of sexual transmission.
  Cornelisse VJ, Traeger MW, Wright EJ, Murphy D, Stoove M, Hellard M, Sacks-Davis R, Asselin J, Fairley CK, Doyle J, Sasawdeusz J
  J Acquir Immune Defic Syndr. 2021 Mar; 87(4):1011-1015
• A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison.
  Palmer A, Papaluca T, Stoové M, Winter R, Pedrana A, Hellard M, Wilson D, Thompson A, Scott N; EC Victoria Partnership.
  Int J Drug Policy. 2021 Mar; 94:103203
• Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatment.
  Palmer AY, Wilkinson A, Aitken C, Dietze P, Dore GJ, Maher L, Sacks-Davis R, Stoové M, Wilson D, Hellard M, Scott N
  J Gastroenterol Hepatol. 2021 Mar; 36(8):2270-2274
• A New Method for Estimating the Incidence of Infectious Diseases.
  McManus H, Callander D, Asselin J, McMahon J, Hoy JF, Templeton DJ, Fairley CK, Donovan B, Pedrana AE, Keen P, Wilson DP, Elliott J, Kaldor J, Liaw ST, Petoumenos K, Holt M, Hellard ME, Grulich AE, Carr A, Stoové MA, Guy RJ
  Am J Epidemiol. 2021 Feb; 190(7):1386-1395
• Integrating episodes of imprisonment and the cascade of care for opioid use disorder.
  Cossar R, Stewart A, Winter R, Curtis M, Dietze P, Ogloff JRP, Stoové M
  Addiction. 2021 Feb; 116(2):427-428
• Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting.
  Scott N, Palmer A, Delport D, Abeysuriya R, Stuart R, Kerr CC, Ministry D, Klein D, Sacks-Davis R, Heath K, Hainsworth S, Pedrana A, Stoové M, Wilson D, Hellard ME
  Med J Aust. 2021 Feb; 214(2):79-83
• Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions.
  Traeger MW, Patel P, Guy R, Hellard ME, Stoové MA for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS)
  AIDS. 2021 Jan; 35(1):155-157
• The phases of hepatitis C elimination: achieving WHO elimination targets.
  Pedrana A, Munari S, Stoové M, Doyle J, Hellard M
  Lancet Gastroenterol Hepatol. 2021 Jan; 6(1):6-8
• Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial.
  Doyle JS, van Santen DK, Iser D, Sasadeusz J, O'Reilly M, Harney B, Traeger MW, Roney J, Cutts JC, Bowring AL, Winter R, Medland N, Fairley CK, Moore R, Tee B, Asselin J, El-Hayek C, Hoy JF, Matthews GV, Prins M, Stoové MA, Hellard ME
  Clin Infect Dis. 2021 Jan; 73(7):e2164–e2172
• Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics.
  Papaluca T, Roberts SK, Strasser SI, Stuart KA, Farrell G, MacQuillan G, Dore GJ, Wade AJ, George J, Hazeldine S, O'Beirne J, Wigg A, Fisher L, McGarity B, Sawhney R, Sinclair M, Thomas J, Valiozis I, Weltman M, Wilson M, Woodward A, Ahlenstiel G, Haque M, Levy M, Prewett E, Sievert W, Sood S, Tse E, Valaydon Z, Bowden S, Douglas M, New K, O'Keefe J, Hellard M, Doyle J, Stoové M, Thompson AJ
  Clin Infect Dis. 2021 Jan; 73(9):e3288-e3295
• Initiation of medications for opioid use disorder shortly before release from prison to promote treatment retention: Strong evidence but compromised policy.
  Curtis M, Larney S, Higgs P, Cossar RD, Winter RJ, Stewart AC, Stoové M
  J Addict Med. 2021 Jan; 15(6):525-526

2020 (27)

• Effect of a mobile phone intervention for female sex workers on unintended pregnancy in Kenya (WHISPER or SHOUT): a cluster-randomised controlled trial.
  Ampt FH, Lim MSC, Agius PA, L'Engle K, Manguro G, Gichuki C, Gichangi P, Chersich MF, Jaoko W, Temmerman M, Stoové M, Hellard M, Luchters S
  Lancet Glob Health. 2020 Dec; 8(12):e1534-e1545
• Patient-specific record linkage between emergency department and hospital admission data for a cohort of people who inject drugs: methodological considerations for frequent presenters.
  Di Rico R, Nambiar D, Gabbe B, Stoové M, Dietze P
  BMC Med Res Methodol. 2020 Nov; 20(1):283
• Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.
  Papaluca T, Craigie A, McDonald L, Edwards A, MacIsaac M, Holmes JA, Jarman M, Lee T, Huang H, Chan A, Lai M, Sundararajan V, Doyle JS, Hellard M, Stoove M, Howell J, Desmond P, Iser D, Thompson A
  PLoS One. 2020 Nov; 15(11):e0242101
• HIV infections among female sex workers in Mombasa, Kenya: current prevalence and trends over 25 years.
  Manguro GO, Gichuki C, Ampt FH, Agius PA, Lim MS, Jaoko WG, Hellard M, L'Engle K, Stoové M, Mandaliya K, Chersich MF, Temmerman M, Luchters S, Gichangi P
  Int J STD AIDS. 2020 Oct; 31(14):1389-1397
• Improved capture of trans and gender-diverse people diagnosed with HIV infection in Victoria following refinement to notification form.
  Ryan KE, Wiggins J, Higgins N, El-Hayek C, Stoové M
  HIV Med. 2020 Sep; 21(10):E23-E24
• Phylogenetic clustering networks among heterosexual migrants with new HIV diagnoses post-migration in Australia.
  Sacks-Davis R, Chibo D, Peach E, Aleksic E, Crowe SM, El Hayek C, Marukutira T, Higgins N, Stoové M, Hellard M
  PLoS One. 2020 Sep; 15(9):e0237469
• Using digital communication technology to increase HIV testing among men who have sex with men and transgender women: Systematic review and meta-analysis
  Veronese V, Ryan KE, Hughes C, Lim MS, Pedrana A, Stoové M
  J Med Internet Res. 2020 Jul; 22(7):e14230
• Sustained, low prevalence of undiagnosed HIV among gay and bisexual men in Sydney, Australia coincident with increased testing and pre-exposure prophylaxis use: results from repeated, bio-behavioural studies 2014-2018.
  Keen P, Lee E, Grulich AE, Prestage G, Guy R, Stoové MA, Bavinton BR, Asselin J, Hammoud MA, Broady T, Duck T, Holt M
  J Acquir Immune Defic Syndr. 2020 Jul; 85(3):e41-e47
• The potential impact of a gel-based point-of-sex intervention in reducing gonorrhoea incidence among gay and bisexual men: a modelling study.
  Traeger MW, Tidhar T, Holt M, Williams C, Wright EJ, Stoové MA, Scott N, Hellard ME
  Sex Transm Dis. 2020 Jul; 47(10):649-657
• The Preferred Qualities of Human Immunodeficiency Virus Testing and Self-Testing Among Men Who Have Sex With Men: A Discrete Choice Experiment.
  Ong JJ, De Abreu Lourenco R, Street D, Smith K, Jamil MS, Terris-Prestholt F, Fairley CK, McNulty A, Hynes A, Johnson K, Chow EPF, Bavinton B, Grulich A, Stoové M, Holt M, Kaldor J, Guy R
  Value Health. 2020 Jul; 23(7):870-879
• The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.
  Traeger MW, Pedrana AE, van Santen DK, Doyle JS, Howell J, Thompson AJ, El-Hayek C, Asselin J, Polkinghorne V, Membrey D, Bramwell F, Carter A, Guy R, Stoové MA, Hellard ME; EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood-borne Viruses and Sexually Transmitted Infections (ACCESS)
  PLoS One. 2020 Jun; 15(6):e0235445
• Privacy-Preserving Record Linkage of Deidentified Records Within a Public Health Surveillance System: Evaluation Study.
  Nguyen L, Stoové M, Boyle D, Callander D, McManus H, Asselin J, Guy R, Donovan B, Hellard M, El-Hayek C
  J Med Internet Res. 2020 Jun; 22(6):e16757
• The response to COVID-19 in prisons must consider the broader mental health impacts for people in prison.
  Stewart A, Cossar R, Stoové M
  Aust N Z J Psychiatry. 2020 Jun; 54(12):1227-1228
• A Mobile Phone-Based Sexual and Reproductive Health Intervention for Female Sex Workers in Kenya: Development and Qualitative Study.
  Ampt FH, L'Engle K, Lim MSC, Plourde KF, Mangone E, Mukanya CM, Gichangi P, Manguro G, Hellard M, Stoové M, Chersich MF, Jaoko W, Agius PA, Temmerman M, Wangari W, Luchters S
  JMIR Mhealth Uhealth. 2020 May; 8(5):e15096
• Trends in human immunodeficiency virus and sexually transmitted Infection testing among gay, bisexual, and other men who have sex with men after rapid scale-up of preexposure prophylaxis in Victoria, Australiaia.
  Ryan KE, Asselin J, Fairley CK, Armishaw J, Lal L, Nguyen L, Murphy D, Traeger M, Hellard M, Hoy J, Stoové M, Wright E; PrEPX Study team
  Sex Transm Dis. 2020 Apr; 47(8):516-552
• Australia needs to increase testing to achieve hepatitis C elimination.
  Scott N, Sacks-Davis R, Wade AJ, Stoové M, Pedrana A, Doyle JS, Thompson AJ, Wilson DP, Hellard ME
  Med J Aust. 2020 Mar; 212(8):365-370
• Gaps in the HIV diagnosis and care cascade for migrants in Australia, 2013-2017: A cross-sectional study.
  Marukutira T, Gray RT, Douglass C, El-Hayek C, Moreira C, Asselin J, Donovan B, Vickers T, Spelman T, Crowe S, Guy R, Stoové M, Hellard M
  PLoS Med. 2020 Mar; 17(3):e1003044
• Point-of-care HIV testing can help achieve UNAIDS targets.
  Hellard M, Ryan KE, Stoové M
  Lancet HIV. 2020 Feb; 7(4):e216-e217
• HIV incidence and factors associated with testing positive for HIV among men who have sex with men and transgender women in Myanmar: data from community-based HIV testing services.
  Veronese V, Traeger M, Oo ZM, Tun TT, Oo NN, Maung H, Hughes C, Pedrana A, Stoové M
  J Int AIDS Soc. 2020 Feb; 23(2):e25454
• HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
  Bowring AL, Ampt FH, Schwartz S, Stoové MA, Luchters S, Baral S, Hellard M
  J Int AIDS Soc. 2020 Feb; 23(2):e25442
• Prevalence of daily tobacco smoking participation among HIV-positive and HIV-negative Australian gay, bisexual and other men who have sex with men.
  Wilkinson A, Quinn B, Draper B, White S, Hellard M, Stoové M
  HIV Med. 2020 Feb; 21(2):e3-e4
• Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets: A retrospective observational study.
  Marukutira T, Gunaratnam P, Douglass C, Jamil MS, McGregor S, Guy R, Gray RT, Spelman T, Horyniak D, Higgins N, Giele C, Crowe SM, Stoové M, Hellard M
  Medicine. 2020 Feb; 99(8):e19289
• "That's the Lowest Place on Earth!" Experiences of the Carceral Spaces of Australian Police Custody for Marginalized Young Men.
  Walker S, Higgs P, Stoové M, Wilson M
  Qual Health Res. 2020 Jan; 30(6):880-893
• Modelling the impact of migrants on the success of the HIV care and treatment program in Botswana.
  Marukutira T, Scott N, Kelly SL, Birungi C, Makhema JM, Crowe S, Stoové M, Hellard M
  PLoS One. 2020 Jan; 15(1):e0226422
• Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure.
  Stoové M, Wallace J, Higgs P, Pedrana A, Goutzamanis S, Latham N, Scott N, Treloar C, Crawford S, Doyle J, Hellard M
  Int J Drug Policy. 2020 Jan; 75:102596
• "A spray bottle and a lollipop stick": An examination of policy prohibiting sterile injecting equipment in prison and effects on young men with injecting drug use histories.
  Walker S, Seear K, Higgs P, Stoové M, Wilson M
  Int J Drug Policy. 2020 Jan; 80:102532
• Harm reduction programs and policy in Australia: barriers and enablers to effective implementation.
  O’Keefe D, Ritter A, Stoové M, Hughes C, Dietze P
  SUCHT. 2020 Jan; 66(1):33-43

2019 (23)

• Prison-based harm reduction measures as part of hepatitis C virus treatment.
  Curtis M, Higgs P, Stoové M
  Lancet Gastroenterol Hepatol. 2019 Dec; 4(12):903
• Retreatment with Elbasvir, Grazoprevir, Sofosbuvir +/- Ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.
  Papaluca T, Sinclair M, Gow P, Pianko S, Sievert W, Arachchi N, Cameron K, Bowden S, O'Keefe J, Doyle J, Stoove M, Hellard M, Iser D, Thompson A
  Liver Int. 2019 Dec; 39(12):2285-2290
• Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia
  Papalucaa T, .O’Keefe J, Bowden S, Doyle JS, Stoové M, Hellard M, Thompson AJ
  J Clin Virol. 2019 Oct; 120:84-87
• Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.
  Williams B, Howell J, Doyle J, Thompson AJ, Draper B, Layton C, Latham N, Bramwell F, Membrey D, Mcpherson M, Roney J, Stoové M, Hellard ME, Pedrana A
  Int J Drug Policy. 2019 Oct; 72:91-98
• Two decades of surveillance data show late presentation among a diverse group of women diagnosed with HIV in Victoria, Australia.
  Moreira C, Boughey A, Ryan KE, Higgins N, Rotty J, West M, Hellard M, Stoové M, El-Hayek C
  Aust N Z J Public Health. 2019 Oct; 43(5):413-418
• A comparative, retrospective analysis of HIV testing among gay, bisexual and other men who have sex with men in Melbourne, Australia.
  Ryan KE, Wilkinson AL, Chow E, Read T, Chen M, Locke P, Leitinger D, Bradshaw C, Pedrana A, Hellard M, Fairley CK, Stoové M
  Aust N Z J Public Health. 2019 Oct; 43(5):419-423
• Risk of Subsequent HIV Infection Following Sexually Transmissible Infections Among Men Who Have Sex With Men.
  Harney BL, Agius PA, El-Hayek C, Fairley CK, Chow EPF, Roth N, Tee BK, Leslie D, Tachedjian G, Hellard M, Stoové M
  Open Forum Infect Dis. 2019 Oct; 6(10):ofz376
• Gonorrhoea gone wild: rising incidence of gonorrhoea and associated risk factors among gay and bisexual men attending Australian sexual health clinics.
  Callander D, Guy R, Fairley CK, McManus H, Prestage G, Chow EPF, Chen M, Connor CCO, Grulich AE, Bourne C, Hellard M, Stoové M, Donovan B
  Sex Health. 2019 Sep; 16(5):457-463
• Assessment of service refinement and its impact on repeat HIV testing by client's access to Australia's universal healthcare system: a retrospective cohort study.
  Ryan KE, Wilkinson AL, Asselin J, Leitinger DP, Locke P, Pedrana A, Hellard M, Stoové M
  J Int AIDS Soc. 2019 Aug; 22(8):e25353
• Australia’s progress towards hepatitis C elimination. Annual Report 2019
  Burnet Institute and Kirby Institute (Prepared by Wilkinson A, Edited by Margaret Hellard M, Stoové, M, Dore G, Grebely J, Pedrana A, Doyle J, Thompson A, Hajarizadeh B, Alavi M, Aitken C)
  Annual Report. 2019 Jul
• Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets.
  Marukutira T, Yin D, Cressman L, Kariuki R, Malone B, Spelman T, Mawandia S, Ledikwe JH, Semo BW, Crowe S, Stoove M, Hellard M, Dickinson D
  Medicine. 2019 Jun; 98(23):e15994
• Use of long-acting reversible contraception in a cluster-random sample of female sex workers in Kenya.
  Ampt FH, Lim MSC, Agius PA, Chersich MF, Manguro G, Gichuki CM, Stoové M, Temmerman M, Jaoko W, Hellard M, Gichangi P, Luchters S
  Int J Gynaecol Obstet. 2019 May; 146(2):184-191
• Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia.
  Schroeder SE, Higgs P, Winter R, Brown G, Pedrana A, Hellard M, Doyle J, Stoové M
  J Int AIDS Soc. 2019 May; 22(5):e25288
• Pathology laboratory surveillance in the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS) of sexually transmitted infections and blood borne viruses: Study Protocol.
  van Gemert C, Guy R, Stoove M, Dimech W, El-Hayek C, Asselin J, Moreira C, Nguyen L, Callander D, Boyle D, Donovan B, Hellard M
  J Med Internet Res. 2019 May; 8(8):e13625
• The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
  Kirwan A, Curtis M, Dietze P, Aitken C, Woods E, Walker S, Kinner S, Ogloff J, Butler T, Stoové M
  J Urban Health. 2019 Apr; 96(3):400-410
• Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
  Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ; PrEPX Study Team
  JAMA. 2019 Apr; 321(14):1380-1390
• Tracking the uptake of outcomes of hepatitis B virus testing using laboratory data in Victoria, 2011-2016; a population-level cohort study.
  van Gemert C, Dimech W, Stoové M , Guy R , Howell J , Bowden S, Nicholson S , Pendle S , Donovan B , Hellard M
  Sexual Health. 2019 Mar; 16:358-366
• Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study.
  Winter RJ, Stoové M, Agius PA, Hellard ME, Kinner SA
  Drug Alcohol Rev. 2019 Mar; 38(3):254-263
• Mortality among people who inject drugs: Ten-year follow-up of the HCV Cohort
  Kimber J, Stoové M, Maher L
  Drug Alcohol Rev. 2019 Mar; 38(3):270-273
• Estimating the syphilis epidemic among gay, bisexual and other men who have sex with men in Australia following changes in HIV care and prevention.
  Wilkinson A, Scott N, Tidhar T, Luong P, El-Hayek C , Wilson D, Fairley C, Zhang L, Leslie D , Roth N , Tee BK , Hellard M , Stoové M
  Sex Health. 2019 Feb; 16(3):254-262
• Understanding HIV and hepatitis C virus risk among incarcerated young men with histories of injecting drug use.
  Walker S, Stoové M, Wilson M, Higgs P.
  Lancet Infect Dis. 2019 Feb; 19(2):130-131
• "We are not gays... don't tell me those things": engaging 'hidden' men who have sex with men and transgender women in HIV prevention in Myanmar.
  Veronese V, Clouse E, Wirtz AL, Thu KH, Naing S, Baral SD, Stoové M, Beyrer C
  BMC Public Health. 2019 Jan; 19(1):63
• Outcomes of treatment for hepatitis C in prisoners using a nurse-led, state-wide model of care.
  Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, Winter R, Scott N, Howell J, Doyle J, Pedrana A, Lloyd A, Stoové M, Hellard M, Iser D, Thompson A
  J Hepatol. 2019 Jan; 70(5):839-846

2018 (29)

• Drug overdose in the ED: a record linkage study examining emergency department ICD-10 coding practices in a cohort of people who inject drugs.
  Di Rico R, Nambiar D, Stoové M, Dietze P
  BMC Health Serv Res. 2018 Dec; 18(1):945
• Evaluation of PrEP eligibility criteria using sexually transmissible infections as HIV risk markers at enrolment in PrEPX, a large Australian HIV pre-exposure prophylaxis trial.
  Cornelisse VJ, Fairley CK, Stoove M, Asselin J, Chow EPF, Price B, Roth NJ, Willcox J, Tee BK, Penn M, Chang CC, Armishaw J, Forgan-Smith G, Wright EJ; PrEPX study team
  Clin Infect Dis. 2018 Nov; 67(12):1847-52
• Monitoring the Control of Sexually Transmissible Infections and Blood-Borne Viruses: Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS).
  Callander D, Moreira C, El-Hayek C, Asselin J, van Gemert C, Watchirs Smith L, Nguyen L, Dimech W, Boyle DI, Donovan B, Stoové M, Hellard M, Guy R
  JMIR Res Protoc. 2018 Nov; 7(11):e11028
• Assessing the Impacts of Integrated Decision Support Software on Sexual Orientation Recording, Comprehensive Sexual Health Testing, and Detection of Infections Among Gay and Bisexual Men Attending General Practice: Observational Study.
  Callander D, Bourne C, Wand H, Stoové M, Hocking JS, de Wit J, Kaldor JM, Donovan B, Pell C, Finlayson R, Baker D, Forssman B, Tee BK, Kefalas B, Duck T, Guy R
  JMIR Med Inform. 2018 Nov; 6(4):e10808
• Lifetime prevalence and correlates of self-harm and suicide attempts among male prisoners with histories of injecting drug use.
  Stewart AC, Cossar R, Dietze P, Armstrong G, Curtis M, Kinner SA, Ogloff JRP, Kirwan A, Stoové M
  Health Justice. 2018 Oct; 6(1):19
• Aiming for 90-90-90 - the importance of understanding the risk factors for HIV exposure and advanced HIV infection in migrant populations and other groups who do not report male-to-male sex.
  Peach E, Lemoh C, Stoové M, Agius P, El Hayek C, Higgins N, Hellard M
  Sex Health. 2018 Oct; 15(5):441-450
• Blood-borne virus transmission in an urban, culturally diverse neighbourhood: results from a cross-sectional bio-behavioural survey using innovative outreach methods in a hard-to-reach population.
  Peach E, Cogger S, Byron K, Francis P, O'Keefe D, Higgs P, Stoove M, Elmore K, Dietze P, Hellard M
  Sex Health. 2018 Oct; 15(1):54-60
• Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
  Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, Stoové M
  Harm Reduct J. 2018 Sep; 15(1):48
• Characteristics of men who have sex with men (MSM) and transgender women (TW) in Myanmar who test frequently for HIV.
  Veronese V, Min Oo Z, Win Thein Z, Draper B, Aung PP, Ryan C, Thant M, Hughes C, Stoovè M
  J Glob Health Rep. 2018 Jul; 2:e2018040
• “I Lost Me Visits” A critical examination of prison drug policy and Its effects on connection to family for incarcerated young men with histories of injecting drug use.
  Walker S, Lancaster K, Stoové M, Higgs P, Wilson M
  Contemporary Drug Problems. 2018 Jun; 45(3):303-328
• Measuring and understanding the attitudes of Australian gay and bisexual men towards biomedical HIV prevention using cross-sectional data and factor analyses.
  Wilkinson AL, Draper BL, Pedrana AE, Asselin J, Holt M, Hellard ME, Stoové M
  Sex Transm Infect. 2018 Jun; 94(4):309-3014
• Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study.
  Ryan KE, Mak A, Stoove M, Price B, Fairley CK, Ruth S, Lal L, Asselin J, El-Hayek C, Nguyen L, Batrouney C, Wilson D, Lockwood J, Murphy D, Cornelisse VJ, Roth N, Willcox J, Chang CC, Armishaw J, Tee BK, Penn M, Forgan-Smith G, Williams C, Montgomery J, Byron K, Coelho A, Allen B, Wiggins J, Kelsall J, Vujovic O, West M, Pierce AB, Gallant D, Bell C, de Wit JBF, Hoy JF, Wesselingh SL, Grant RM, Wright EJ
  Front Public Health. 2018 May; 6:151
• Implications of survey labels and categorisations for understanding drug use in the context of sex among gay and bisexual men in Melbourne, Australia.
  Ryan KE, Wilkinson AL, Pedrana A, Quinn B, Dietze P, Hellard M, Stoové M
  Int J Drug Policy. 2018 May; 55:183-186
• Undiagnosed HIV infections among gay and bisexual men increasingly contribute to new infections in Australia.
  Gray RT, Wilson DP, Guy RJ, Stoové M, Hellard ME, Prestage GP, Lea T, de Wit J, Holt M
  J Int AIDS Soc. 2018 Apr; 21(4):e25104
• Re-Wired: treatment and peer support for men who have sex with men who use methamphetamine.
  Burgess K, Parkhill G, Wiggins J, Ruth S, Stoovè M
  Sex Health. 2018 Apr; 15(2):157-159
• Comfort Relying on HIV Pre-exposure Prophylaxis and Treatment as Prevention for Condomless Sex: Results of an Online Survey of Australian Gay and Bisexual Men.
  Holt M, Draper BL, Pedrana AE, Wilkinson AL, Stoové M
  AIDS Behav. 2018 Mar; 22(11):3617-3626
• Achieving 90-90-90 HIV targets will not be enough to achieve the HIV incidence reduction target in Australia.
  Scott N, Stoové M, Kelly SL, Wilson DP, Hellard ME
  Clin Infect Dis. 2018 Mar; 66(7):1019-1023
• Comparing Australian gay and bisexual men with undiagnosed and recently diagnosed HIV infection to those in the National HIV Registry.
  Down I, Prestage G, Brown G, Ellard J, Guy R, Hellard M, Wilson D, de Wit J, Stoové M, Holt M
  Sex Health. 2018 Mar; 15(3):276-281
• Effects of Pre-exposure Prophylaxis for the Prevention of HIV Infection on Sexual Risk Behavior in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
  Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, Stoové MA
  Clin Infect Dis. 2018 Mar; 67(5):676-686
• A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.
  Marukutira T, Stoové M, Lockman S, Mills LA, Gaolathe T, Lebelonyane R, Jarvis JN, Kelly SL, Wilson DP, Luchters S, Crowe SM, Hellard M
  J Int AIDS Soc. 2018 Mar; 21(3):e25090
• Are people who inject drugs frequent users of emergency department services? A cohort study (2008-2013).
  Nambiar D, Spelman T, Stoové M, Dietze P
  Subst Use Misuse. 2018 Feb; 53(3):457-465
• Acceptability of Peer-Delivered HIV Testing and Counselling Among Men Who Have Sex with Men (MSM) and Transgender Women (TW) in Myanmar.
  Veronese V, Oo ZM, Thein ZW, Aung PP, Draper BL, Hughes C, Ryan C, Pedrana A, Stoové M
  AIDS Behav. 2018 Feb; 22(8):2426-2434
• Declining prevalence of undiagnosed HIV in Melbourne: results from community-based bio-behavioural studies of gay and bisexual men.
  Stoové M, Asselin J, Pedrana A, Lea T, Hellard M, Wilson D, Prestage G, de Wit J, Holt M
  Aust N Z J Public Health. 2018 Feb; 42(1):57-61
• Substance Use After Release from Prison (Book Chapter)
  Larney S, Stoové M, Kinner SA
  "in ""Drug Use in Prisoners: Epidemiology, Implications, and Policy Responses"" Eds Stuart A, Kinner and Josiah D. Jody Rich ". 2018 Feb; Chapter 6
• The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia.
  Cossar R, Stoové M, Kinner SA, Dietze P, Aitken C, Curtis M, Kirwan A, Ogloff JRP
  Health Justice. 2018 Jan; 6(1):1
• Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour.
  Scott N, Stoové M, Wilson DP, Keiser O, El-Hayek C, Doyle J, Hellard M
  J Int AIDS Soc. 2018 Jan; 21(1):e25059
• Narratives of Young Men With Injecting Drug Use Histories Leaving Adult Prison.
  Walker S, Higgs P, Stoové M, Wilson M
  Int J Offender Ther Comp Criminol. 2018 Jan; ;62(12):3681-3707
• Acceptability and HIV prevention benefits of a peer-based model of rapid point of care HIV testing for Australian gay, bisexual and other men who have sex with men.
  Leitinger D, Ryan KE, Brown G, Pedrana A, Wilkinson AL, Ryan C, Hellard M, Stoové M
  AIDS Behav. 2018 Jan; 22(1):178-189
• Syndromic management of sexually transmissible infections in resource-poor settings: a systematic review with meta-analysis of the abnormal vaginal discharge flowchart for Neisseria gonorrhoea and Chlamydia trachomatis.
  van Gemert C, Hellard M, Bradshaw CS, Fowkes FJI, Agius PA, Stoove M, Bennett CM
  Sex Health. 2018 Jan; 15(1):1-12

2017 (15)

• Trial and error: evaluating and refining a community model of HIV testing in Australia.
  Ryan KE, Pedrana A, Leitinger D, Wilkinson AL, Locke P, Hellard ME, Stoové M
  BMC Health Serv Res. 2017 Oct; 17(1):692
• Knowledge and practices of chronic hepatitis B virus testing by general practitioners in Victoria, Australia, 2014-15.
  van Gemert C, Howell J, Wang J, Stoové M, Cowie B, Allard N, Enright C, Dunn E, Towell V, Hellard M
  Aust Fam Physician. 2017 Sep; 46(9):683-689
• A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008-2013.
  Nambiar D, Stoové M, Hickman M, Dietze P
  BMJ Open. 2017 Aug; 7(8):e014854
• WHISPER or SHOUT study: protocol of a cluster-randomised controlled trial assessing mHealth sexual reproductive health and nutrition interventions among female sex workers in Mombasa, Kenya.
  Ampt FH, Mudogo C, Gichangi P, Lim MSC, Manguro G, Chersich M, Jaoko W, Temmerman M, Laini M, Comrie-Thomson L, Stoové M, Agius PA, Hellard M, L'Engle K, Luchters S
  BMJ Open. 2017 Aug; 7(8):e017388
• Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar.
  Draper BL, Oo ZM, Thein ZW, Aung PP, Veronese V, Ryan C, Thant M, Hughes C, Stoové M
  J Int AIDS Soc. 2017 Jul; 20(1):21885
• New hepatitis C antiviral treatments eliminate the virus.
  Doyle JS, Thompson AJ, Higgs P, Stoove M, Dietze PM, Hellard ME
  Lancet. 2017 Jul; 390(10092):358-359
• Injecting drug use in low and middle income countries: opportunities to improve care and prevent harm.
  O'Keefe D, Stoové M, Doyle J, Dietze P, Hellard M.
  J Viral Hepat. 2017 Jun; 24(9):714-724
• Longitudinal changes in personal wellbeing in a cohort of people who inject drugs.
  Scott N, Carrotte ER, Higgs P, Stoové MA, Aitken CK, Dietze PM
  PLoS One. 2017 May; 12(5):e0178474
• Frequent emergency department presentations among people who inject drugs: A record linkage study.
  Nambiar D, Stoové M, Dietze P
  Int J Drug Policy. 2017 May; 44:115-120
• Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.
  Lal L, Audsley J, Murphy D, Fairley CK, Stoove M, Roth N, Moore R, Tee BK, Puratmaja N, Anderson PL, Leslie D, Grant RM, De Wit J, Wright E; VicPrEP Study Team.
  AIDS. 2017 May; 31(12):1709-1714
• Wilkinson et al. Respond to "Latent Transition Analyses in Clinical Cohorts".
  Wilkinson AL, El-Hayek C, Fairley CK, Roth N, Tee BK, McBryde E, Hellard M, Stoové M
  Am J Epidemiol. 2017 Apr; 185(8):639-640
• Utility of risk-based chlamydia testing in primary care: analysis of retrospective surveillance data among women in Melbourne, Australia.
  Wilkinson AL, McNamee K, El-Hayek C, Chow EP, Bradshaw CS, Roth N, Tee BK, Stoové M, Hellard M
  Sex Health. 2017 Apr; 14(3):268-273
• The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.
  Aitken CK, Agius PA, Higgs PG, Stoové MA, Bowden DS, Dietze PM
  Epidemiol Infect. 2017 Mar; 145(4):796-801
• Measuring transitions in sexual risk among Men Who Have Sex With Men: The novel use of latent class and latent transition analysis in HIV sentinel surveillance.
  Wilkinson AL, El-Hayek C, Fairley CK, Roth N, Tee BK, McBryde E, Hellard M, Stoové M
  Am J Epidemiol. 2017 Mar; 185(8):627-635
• Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system.
  Pierce AB, El-Hayek C, McCarthy D, Armishaw J, Watson K, Wilkinson A, Price B, Wright EJ, Hoy JF, Stoové MA
  Sex Health. 2017 Feb; 14(2):179-87

2016 (13)

• Achieving development goals for HIV, tuberculosis and malaria in sub-Saharan Africa through integrated antenatal care: barriers and challenges.
  Fowkes FJ, Draper BL, Hellard M, Stoové M
  BMC Med. 2016 Dec; 14(1):202
• A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol.
  Callander D, Stoové M, Carr A, Hoy JF, Petoumenos K, Hellard M, Elliot J, Templeton DJ, Liaw S, Wilson DP, Grulich A, Cooper DA, Pedrana A, Donovan B, McMahon J, Prestage G, Holt M, Fairley CK, McKellar-Stewart N, Ruth S, Asselin J, Keen P, Cooper C, Allan B, Kaldor JM, Guy R
  BMC Infect Dis. 2016 Dec; 16(1):752
• A nurse-led intervention improved blood-borne virus testing and vaccination in Victorian prisons.
  Winter RJ, White B, Kinner SA, Stoové M, Guy R, Hellard ME
  Aust N Z J Public Health. 2016 Oct; 40(6):592-594
• Resumption of injecting drug use following release from prison in Australia.
  Winter RJ, Young JT, Stoové M, Agius PA, Hellard ME, Kinner SA
  Drug Alcohol Depend. 2016 Sep; 168:104-111
• A 'test and treat' prevention strategy in Australia requires innovative HIV testing models: a cohort study of repeat testing among 'high-risk' men who have sex with men.
  Wilkinson AL, El-Hayek C, Spelman T, Fairley CK, Leslie D, McBryde ES, Hellard M, Stoové M
  Sex Transm Infect. 2016 Sep; 92(6):464-466
• Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia.
  Scott N, Carrotte ER, Higgs P, Cogger S, Stoové MA, Aitken CK, Dietze PM
  Drug and Alcohol Dependence. 2016 Aug; 168:140-146
• Characteristics of gay, bisexual and other men who have sex with men testing and retesting at Australia’s first shop-front rapid point-of-care HIV testing service.
  Ryan KE, Wilkinson AL, Leitinger D, El-Hayek C, Ryan C, Pedrana A, Hellard M, Stoové M
  Sex Health. 2016 Aug; 13(6):560-567
• Alcohol and other drug treatment policy in Australia.
  Alison Ritter, Mark Stoove
  Med J Aust. 2016 Mar; 204(4):138
• It’s time: a case for trialling a needle and syringe program in Australian prisons.
  Stoové M
  HIV Australia. 2016 Mar; 14(1):6-8
• Improving the identification of priority populations to increase hepatitis B testing rates, 2012.
  van Gemert C, Wang J, Simmons J, Cowie B, Boyle D, Stoove M, Enright C, Hellard M
  BMC Public Health. 2016 Feb; 16(1):95
• HIV and Sexual Risk Among Men Who Have Sex With Men and Women in Asia: A Systematic Review and Meta-Analysis.
  Bowring AL, Veronese V, Doyle JS, Stoové M, Hellard M
  AIDS Behav. 2016 Jan; 20(10):2243-2265
• One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort.
  Quinn B, Stoové MA, Dietze P
  J Subst Use. 2016 Jan; 21(3):279-286
• The Impact of a Social Marketing Campaign on HIV and Sexually Transmissible Infection Testing Among Men Who Have Sex With Men in Australia.
  Wilkinson AL, Pedrana AE, El-Hayek C, Vella AM, Asselin J, Batrouney C, Fairley CK, Read TR, Hellard M, Stoové M
  Sex Transm Dis. 2016 Jan; 43(1):49-56

2015 (19)

• Modelling the Impact of Condom Distribution on the Incidence and Prevalence of Sexually Transmitted Infections in an Adult Male Prison System.
  Scott N, McBryde E, Kirwan A, Stoové M
  PLoS One. 2015 Dec; 10(12):e0144869
• Mortality in the Melbourne injecting drug user cohort study (MIX).
  Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P
  Harm Reduct J. 2015 Dec; 12(1):55
• Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
  Horyniak D, Agius PA, Degenhardt L, Reddel S, Higgs P, Aitken C, Stoové M, Dietze P
  Subst Use Misuse. 2015 Nov; 50(13):1650-1659
• The prevalence and correlates of undiagnosed HIV among Australian gay and bisexual men: results of a national, community-based, bio-behavioural survey.
  Holt M, Lea T, Asselin J, Hellard M, Prestage G, Wilson D, de Wit J, Stoové M
  J Int AIDS Soc. 2015 Nov; 18(1):20526
• Going tobacco free in Australian prisons – increasing tattooing harm?
  Treloar C, Baldry E, Higgs P, Dietze P, Stoové M, Lloyd A
  Int J Prisoner Health. 2015 Nov; 11(4):Viewpoint
• Salvaging a prison needle and syringe program trial in Australia requires leadership and respect for evidence.
  Stoové M, Treloar CJ, Maher L, Tyrrell H, Wallace J
  Med J Aust. 2015 Oct; 203(8):319-320
• Development and pilot of a framework to evaluate reproductive health call centre services: experience of Marie Stopes international.
  Yagnik P, Gold J, Stoove M, Reichwein B, van Gemert C, Corby N, Lim MS
  BMC Health Serv Res. 2015 Sep; 15(1):398
• Correlates of property crime in a cohort of recently released prisoners with a history of injecting drug use.
  Kirwan A, Quinn B, Winter R, Kinner SA, Dietze P, Stoové M
  Harm Reduct J. 2015 Aug; 12(1):23
• Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors.
  Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P
  Drug Alcohol Depend. 2015 Jun; 154:208-213
• Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.
  Winter RJ, Stoové M, Degenhardt L, Hellard ME, Spelman T, Jenkinson R, McCarthy DR, Kinner SA
  Drug Alcohol Depend. 2015 Jun; 153:43-49
• "Seek, Test, Treat" Lessons from Australia: A Study of HIV testing patterns from a cohort of men who have sex with men.
  Wilkinson AL, El-Hayek C, Spelman T, Fairley C, Leslie D, McBryde E, Hellard M, Stoové M
  J Acquir Immune Defic Syndr. 2015 Mar; 69(4):460-465
• The use of social networking platforms for sexual health promotion: identifying key strategies for successful user engagement.
  Veale HJ, Sacks-Davis R, Weaver ERN, Pedrana AE, Stoové MA, Hellard ME
  BMC Public Health. 2015 Feb; 15(1):85
• Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis.
  Aspinall EJ, Doyle JS, Corson S, Hellard ME, Hunt D, Goldberg D, Nguyen T, Falck-Ytter Y, Morgan RL, Smith B, Stoové M, Wiktor SZ, Hutchinson S
  Eur J Epidemiol. 2015 Feb; 30(2):115-129
• Recording the sexual orientation of male patients attending general practice.
  Callander D, Bourne C, Pell C, Finlayson R, Forssman B, Baker D, de Wit J, Hocking J, Stoové M, Donovan B, Kaldor J, Guy R
  Fam Pract. 2015 Jan; 32(1):35-40
• Sexually transmitted infections among transgender people and men who have sex with men in Port Vila, Vanuatu.
  Veronese V, van Gemert C, Bulu S, Kwarteng T, Bergari I, Badman S, Vella A, Stoové M
  Western Pac Surveill Response J. 2015 Jan; 6(1):55-59
• A reality check for aspirational targets to end HIV.
  Wilson DP, Stoové MA, Hellard M
  Lancet HIV. 2015 Jan; 2(1):e11
• Paying the price in an era of HIV treatment as prevention: a retrospective study of the cost burden of HIV treatment for people living with HIV in Victoria, Australia.
  Wilkinson AL, McMahon J, Cheah Y, Bradshaw CS, El-Hayek C, Stoové M
  Sex Health. 2015 Jan; 12(1):34-38
• Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012.
  Nambiar D, Weir A, Aspinall EJ, Stoové M, Hutchinson S, Dietze P, Waugh L, Goldberg DJ
  Drug Alcohol Depend. 2015 Jan; 147:215-221
• How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia.
  Horyniak D, Stoové M, Degenhardt L, Aitken C, Kerr T, Dietze P
  Int J Drug Policy. 2015 Jan; 26(1):43-50

2014 (11)

• Effects of HIV antiretroviral therapy on sexual and injecting risk-taking behaviour: a systematic review and meta-analysis.
  Doyle JS, Degenhardt L, Pedrana AE, McBryde ES, Guy R, Stoové MA, Weaver E, Grulich AE, Lo YR, Hellard M
  Clin Infect Dis. 2014 Aug; 59(10):1483-1494
• A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs.
  Nambiar D, Stoové M, Dietze P
  BMC Health Serv Res. 2014 Jul; 14:308
• Commentary on Degenhardt et al. (2014): Access to opioid substitution therapy in prison is not enough—the crucial role of post-release retention in preventing drug-related harms
  Stoové MA, Kinner S
  Addiction. 2014 Jul; 109(8):1318-1319
• PRONTO! Community-Based HIV Rapid Testing Evaluation Report - Stage 1.
  Ryan K, Leitinger D, Pedrana A, Wilkinson A, Stoové M
  Report for the Centre for Population Health, Burnet Institute: Melbourne, Australia. 2014 Jul
• Outcome evaluation of HIV prevention initiatives 2012 – 2013 in men who have sex with men in Victoria.
  Vella A., Wilkinson A., Pedrana, A., Stoové, M
  Technical Report for Centre for Population Health, Burnet Institute: Melbourne, Australia. 2014 Jul
• Chlamydia Prevalence and Associated Behaviours Among Female Sex Workers in Vanuatu: Results from an Integrated Bio-behavioural Survey, 2011.
  van Gemert C, Stoové M, Kwarteng T, Bulu S, Bergeri I, Wanyeki I, Badman S, Malverus J, Vella A, Tarivonda L, Johnston LG
  AIDS Behav. 2014 May; 18(10):2040-2049
• Moving towards HIV treatment as prevention.
  Stoové MA, Pedrana AE, Hellard ME
  Microbiol Aust. 2014 May; 35(2):88-90
• No Drama: Key Elements to the Success of an HIV/STI-Prevention Mass-Media Campaign.
  Pedrana AE, Hellard ME, Higgs P, Asselin J, Batrouney C, Stoové M
  Qual Health Res. 2014 Apr; 24(5):695-705
• Making the most of a brave new world: Opportunities and considerations for using Twitter as a public health monitoring tool.
  Stoové MA, Pedrana AE
  Prev Med. 2014 Mar; 63:109-111
• Rapid HIV testing increases the rate of HIV detection in men who have sex with men: using rapid HIV testing in a primary care clinic.
  Eu B, Roth N, Stoové M, O'Reilly M, Clarke E
  Sex Health. 2014 Mar; 11(1):89-90
• Trends in chlamydia positivity among heterosexual patients from the Victorian Primary Care Network for Sentinel Surveillance, 2007-2011.
  Lim MS, El-Hayek C, Goller JL, Fairley CK, Nguyen PL, Hamilton RA, Henning DJ, McNamee KM, Hellard ME, Stoove MA
  Med J Aust. 2014 Feb; 200(3):166-169

2013 (15)

• The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids.
  Nielsen S, Bruno R, Degenhardt L, Stoové MA, Fischer JA, Carruthers SJ, Lintzeris N
  Med J Aust. 2013 Nov; 199(10):696-699
• Opt-Out and Opt-In Testing Increases Syphilis Screening of HIV-Positive Men Who Have Sex with Men in Australia.
  Guy R, El-Hayek C, Fairley CK, Wand H, Carr A, McNulty A, Hoy J, Bourne C, McAllister J, Tee BK, Baker D, Roth N, Stoové M, Chen M
  PLoS One. 2013 Aug; 8(8):e71436
• An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users.
  Quinn B, Stoové M, Papanastasiou C, Dietze P
  Int J Drug Policy. 2013 Jul; 24(6):619-23
• Evaluation of the Introduction of Condoms and Dental Dams into Victorian Prisons, Stage Two and Three – Final Report.
  Kirwan A, Scott N, McBryde E, Stoové M
  Technical Report for Centre for Population Health, Burnet Institute: Melbourne, Australia.. 2013 Jul
• Vanuatu Integrated Bio‐Behavioural Survey and Population Size Estimation with Female Sex Workers in Port Vila, Vanuatu, 2011
  van Gemert C, with input from Kwarteng T, Bulu S, Theatre W, Bergeri I, Malverus J, Wanyeki I, Badman S, Tarivonda L, Vella A, Stoové M
• Establishing the Melbourne injecting drug user cohort study (MIX): rationale, methods, and baseline and twelve-month follow-up results.
  Horyniak D, Higgs P, Jenkinson R, Degenhardt L, Stoové M, Kerr T, Hickman M, Aitken C, Dietze P
  Harm Reduct J. 2013 Jun; 10(1):11
• Sexual Health Promotion on Social Networking Sites: A Process Evaluation of the FaceSpace Project.
  Nguyen P, Gold J, Pedrana A, Chang S, Howard S, Ilic O, Hellard M, Stoové M
  J Adolesc Health. 2013 Apr; 53(1):98-104
• Increases in newly acquired HIV infections in Victoria, Australia: epidemiological evidence of successful prevention?
  Feigin A, El-Hayek C, Hellard M, Pedrana A, Donnan E, Fairley C, Tee BK, Stoové M
  Sex Health. 2013 Apr; 10(2):166-170
• Factors associated with professional support access among a prospective cohort of methamphetamine users.
  Quinn B, Stoové M, Dietze P
  J Subst Abuse Treat. 2013 Mar; 45(2):235-241
• Queer as F**k: Reaching and Engaging Gay Men in Sexual Health Promotion through Social Networking Sites.
  Pedrana A, Hellard M, Gold J, Ata N, Chang S, Howard S, Asselin J, Ilic O, Batrouney C, Stoové M
  J Med Internet Res. 2013 Feb; 15(2):e25
• The relationship between alcohol use and injecting drug use: Impacts on health, crime and wellbeing.
  Dietze P, Jenkinson R, Aitken C, Stoové M, Jolley D, Hickman M, Kerr T
  Drug Alcohol Depend. 2013 Feb; 128(1-2):111-115
• Methamphetamine use in Melbourne, Australia: baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence.
  Quinn B, Stoové M, Papanastasiou C, Dietze P
  J Subst Use. 2013 Jan; 18(5):349-362
• An urgent need to scale-up injecting drug harm reduction services in Tanzania: Prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
  Bowring AL, Luhmann N, Pont S, Debaulieu C, Derozier S, Asouab F, Toufik A, van Gemert C, Dietze P, Stoové M
  Int J Drug Policy. 2013 Jan; 24(1):78-81
• Is rectal gonorrhoea a lead indicator of HIV transmission among men who have sex with men in Victoria, Australia?
  Wilkinson AL, Lim MS, Stoové M, Fairley CK, Chen M, El-Hayek C, Denham I, Hellard M
  Sex Health. 2013 Jan; 10(2):188-189
• A cross-sectional study of emergency department visits by people who inject drugs.
  Aitken C, Kerr T, Hickman M, Stoové M, Higgs P, Dietze P
  Emerg Med J. 2013 Jan; 30(5):421-422

2012 (9)

• Stop the Drama Downunder: A Social Marketing Campaign Increases HIV/Sexually Transmitted Infection Knowledge and Testing in Australian Gay Men.
  Pedrana A, Hellard M, Guy R, El-Hayek C, Gouillou M, Asselin J, Batrouney C, Nguyen P, Stoovè M
  Sex Transm Dis. 2012 Aug; 39(8):651-658
• Correlates of Chlamydia trachomatis infection in a primary care sentinel surveillance network.
  Lim MS, Goller JL, Guy R, Gold J, Stoové M, Hocking JS, Fairley CK, Henning D, McNamee K, Owen L, Sheehan P, Hellard ME
  Sex Health. 2012 Jul; 9(3):247-253
• Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia.
  Hellard ME, Jenkinson R, Higgs P, Stoové MA, Sacks-Davis R, Gold J, Hickman M, Vickerman P, Martin NK
  Med J Aust. 2012 Jun; 196(10):638-641
• Identifying newly acquired cases of hepatitis C using surveillance: a literature review.
  Sacks-Davis R, Van Gemert C, Bergeri I, Stoové M, Hellard M
  Epidemiol Infect. 2012 Jun; 140(11):1925-1934
• Prevalence survey of dermatological conditions in mountainous north India.
  Grills N, Grills C, Spelman T, Stoové M, Hellard M, El-Hayek C, Singh R
  Int J Dermatol. 2012 May; 51(5):579-587
• Developing health promotion interventions on social networking sites: recommendations from The FaceSpace Project.
  Gold J, Pedrana AE, Stoové MA, Chang S, Howard S, Asselin J, Ilic O, Batrouney C, Hellard ME
  J Med Internet Res. 2012 Feb; 14(1):e30
• Incidence and risk factors associated with chlamydia in men who have sex with men: a cohort analysis of Victorian Primary Care Network for Sentinel Surveillance data.
  Wilkinson A, El-Hayek C, Fairley CK, Leslie D, Roth N, Tee BK, Hellard ME, Stoové M
  Sex Transm Infect. 2012 Feb; 88(5):319-324
• High rates of undiagnosed HIV infections in a community sample of gay men in Melbourne, Australia.
  Pedrana AE, Hellard ME, Wilson K, Guy R, Stoové M
  JAIDS. 2012 Jan; 59(1):94-99
• The difference in self-reported and biological measured HIV prevalence: Implications for HIV prevention.
  Pedrana AE, Hellard ME, Guy R, Wilson K, Stoové M
  AIDS Behav. 2012 Jan; 16(6):1454-1463

2011 (9)

• Sexual history taking and sexually transmissible infection screening practices among men who have sex with men: a survey of Victorian general practitioners.
  Barber B, Hellard M, Jenkinson R, Spelman T, Stoové M
  Sex Health. 2011 Sep; 8(3):349-354
• Risk factors for HIV seroconversion in men who have sex with men in Victoria, Australia: results from a sentinel surveillance system.
  Guy RJ, Spelman T, Stoové M, El-Hayek C, Goller J, Fairley CK, Leslie D, Tee B, Roth N, Grulich AE, Hellard ME
  Sex Health. 2011 Sep; 8(3):319-329
• Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
  Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L
  Lancet. 2011 Aug; 378(9791):571-583
• A systematic examination of the use of Online social networking sites for sexual health promotion.
  Gold J, Pedrana AE, Sacks-Davis R, Hellard ME, Chang S, Howard S, Keogh L, Hocking JS, Stoové MA
  BMC Public Health. 2011 Jul; 11:583
• Counting the cost: estimating the number of deaths among recently released prisoners in Australia.
  Kinner SA, Preen DB, Kariminia A, Butler T, Andrews JY, Stoové M, Law M
  Med J Aust. 2011 Jul; 195(2):64-68
• The Australian national binge drinking campaign: campaign recognition among young people at a music festival who report risky drinking.
  van Gemert C, Dietze P, Gold J, Sacks-Davis R, Stoové M, Vally H, Hellard M
  BMC Public Health. 2011 Jun; 11:482
• HIV seroconversions among male non-occupational post-exposure prophylaxis service users: a data linkage study.
  Pierce AB, Yohannes K, Guy R, Watson KM, Armishaw J, Price B, Hoy JF, Wright EJ, Stoové MA
  Sex Health. 2011 Jun; 8(2):179-183
• Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
  Nielsen S, Bruno R, Lintzeris N, Fischer J, Carruthers S, Stoové M
  Drug Alcohol Rev. 2011 May; 30(3):291-299
• Monitoring emerging drug trends: Psychometrics and validity in earlier warning systems.
  Mounteney J, Stoové M, Haugland S
  Addiction Res & Theory. 2011 Jan; 19(1):32-39

2010 (5)

• The changing age distribution of men who have sex with men diagnosed with HIV in Victoria.
  El-Hayek C, Bergeri I, Hellard ME, Pedrana AE, Higgins N, Breschkin A, Stoové M
  Med J Aust. 2010 Dec; 193(11-12):655-658
• Establishing a linked sentinel surveillance system for blood-borne viruses and sexually transmissible infections: methods, system attributes and early findings.
  Goller JL, Guy RJ, Gold J, Lim MS, El-Hayek C, Stoové MA, Bergeri I, Fairley CK, Leslie DE, Clift P, White B, Hellard ME
  Sex Health. 2010 Dec; 7(4):425-433
• The self-reported personal wellbeing of a sample of Australian injecting drug users.
  Dietze P, Stoové M, Miller P, Kinner S, Bruno R, Alati R, Burns L
  Addiction. 2010 Dec; 105(12):2141-2148
• Examination of the stability and consistency of investigative interviewer performance across similar mock interview contexts
  Powell MB, Hughes-Scholes CH, Cavezza C, Stoové MA
  Legal Criminolog Psychol. 2010 Jan; 15(2):243-60
• Examination of the consistency of interviewer performance across three distinct interview contexts.
  Powell MB, Cavezza C, Hughes-Scholes CH, Stoové MA
  Psychol Crime Law. 2010 Jan; 16:585-600

2009 (3)

• Interrelationships between HIV/AIDS and risk behavior prejudice among medical students in Southern China.
  Chan KY, Yang Y, Li ZR, Stoové MA, Reidpath DD
  Curr HIV Res. 2009 Nov; 7(6):601-611
• Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
  Stoové MA, Dietze PM, Jolley D
  Drug Alcohol Rev. 2009 Jul; 28(4):347-352
• The impact of immigration on the burden of HIV infection in Victoria, Australia.
  Horyniak D, Stoové M, Yohannes K, Breschkin A, Carter T, Hatch B, Tomnay J, Hellard M, Guy R
  Sex Health. 2009 Jun; 6(2):123-128

2008 (6)

• Investigation of pharmaceutical misuse amongst drug treatment clients.
  S. Nielson, B. Raimondo, Susan Carruthers, J. Fisher, N. Lintzeris, M. Stoové
  Turning Point Alcohol and Drug Centre. 2008 Dec; Final Report 2008
• Stigma, social reciprocity and exclusion of HIV/AIDS patients with illicit drug histories: a study of Thai nurses' attitudes.
  Chan KY, Stoové MA, Reidpath DD
  Harm Reduct J. 2008 Aug; 5:28
• Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS).
  Stoové MA, Dietze PM, Aitken CK, Jolley D
  Drug Alcohol Depend. 2008 Aug; 96(3):281-285
• Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.
  Stoové MA, Fry CL, Lintzeris N
  Harm Reduct J. 2008 Apr; 5:12
• The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users.
  Norman J, Walsh NM, Mugavin J, Stoové MA, Kelsall J, Austin K, Lintzeris N
  Harm Reduct J. 2008 Feb; 5:8
• Stigmatization of AIDS patients: disentangling Thai nursing students' attitudes towards HIV/AIDS, drug use, and commercial sex.
  Chan KY, Stoové MA, Sringernyuang L, Reidpath DD
  AIDS Behav. 2008 Jan; 12(1):146-157

2007 (1)

• Gender differences in seeking care for hepatitis C in Australia
  Temple‐Smith M, Stoové M, Smith A, O'Brien M, Mitchell D, Banwell C, Bammer G, Jolley D, Gifford S
  J Subst Use. 2007 Jan; 12(1):59-70

2006 (2)

• Mortality in a cohort of opiate and amphetamine users in Perth, Western australia: Comment on Bartu et al. (2006).
  Mark Stoové
  Addiction. 2006 Oct; 101(10):1523-4; author reply 1524
• A survey of regular ecstasy users' knowledge and practices around determining pill content and purity: Implications for policy and practice.
  Jennifer W. Johnston, Monica J Barratt, Craig L Fry, Stuart Kinner, Mark Stoove, Louisa J. Degenhardt, Jessica F. George, Rebecca Jenkinson, Matthew Dunn, Raimondo Bruno
  Int J Drug Policy. 2006 Mar; 17:464-472

2005 (3)

• Victorian trends in ecstasy and related drug markets 2004: Findings from the Party Drugs Initiative (PDI)
  Mark A Stoové, Anne-Marie Laslett, Monica Barratt
  National Drug and Alcohol Research Centre, University of New South Wales Report. 2005 Aug
• The impact of injecting drug use status on hepatitis C-related referral and treatment.
  M A Stoové, S M Gifford, G J Dore
  Drug Alcohol Dep. 2005 Feb; 77(1):81-86
• Australian men's experiences of living with hepatitis C virus: results from a cross-sectional survey.
  Sandra M Gifford, Mary L O'Brien, Anthony Smith, Meredith Temple-Smith, Mark Stoové, Drew Mitchell, Damien Jolley
  J Gastroenterol Hepatol. 2005 Jan; 20(1):79-86

2003 (3)

• An investigation of RPE-heart rate and the RPE-lactate relationships in elite athletes.
  Stoové MA
  Ph.D. thesis. 2003 Dec
• Australian women's experiences of living with hepatitis C virus: results from a cross-sectional survey.
  Sandra M Gifford, Mary L O'Brien, Gabrile Bammer, Cathy Banwell, Mark Stoové
  J Gastroenterol Hepatol. 2003 Jul; 18(7):841-850
• What are we looking at, and how big is it?
  Mark A Stoové, Mark B Andersen
  Physical Ther Sport. 2003 Jan; 4(2):93-97

2001 (1)

• Can Aerobic Exercise Training Affect Health-Related Quality of Life for People With Multiple Sclerosis?
  Georgina Sutherland, Mark B. Andersen, Mark A. Stoové
  J Sport Exercise Psychol. 2001 Jun; 23(2)

1998 (1)

• The sanctity of p < .05 obfuscates good stuff: A comment on Kerr and Goss
  Anderson MB, Stoové M
  J Appl Sport Psychol. 1998 Jan; 10(1):168-173

1997 (1)

• Requesting poster papers: a problem of compliance.
  M B Andersen, M A Stoove, D T Martin
  Aust J Sci Med Sport. 1997 Sep; 29(3):75-76

News Articles (98)

2023 (2)

• Reducing the overdose rate for people who inject drugs after they’re released from prison
• Twice as many Victorians may have had COVID-19 in January 2022 than reported, new analysis reveals

2022 (5)

• 2022 in Review: July to December
• Australia falling behind in goal to eliminate hepatitis C, new report shows
• Elimination of hepatitis C the focus of new funding grant
• Time to explore decriminalisation of drug use on International Overdose Awareness Day
• Burnet research honoured at AIDS 2022

2021 (7)

• How to have a safe(r) summer with COVID-19 cases rising in our communities.
• As Melbourne cautiously opens up today, what lies ahead?
• Burnet Support of Congress Vaccination strategy
• More Victorians intend to get vaccinated for COVID-19 but mixed understanding of the implications of being vaccinated
• New Burnet modelling: Tougher restrictions in NSW's 12 LGAs of Concern 'turns the corner' on cases, not just rising vaccination levels
• World-first study shows effectiveness of masks in preventing COVID transmission
• COVID-19 Timeline: How Science Matters

2020 (9)

• 2020 in Review: January to June
• Testing, support vital for post-lockdown PrEP
• IMPACT special edition now online!
• NHMRC support for Burnet hepatitis research
• Councils call for community-based response
• Drug pricing a barrier to HIV elimination
• Testing rate fall leaves thousands of Australians at risk of hepatitis C
• HIV diagnosis and treatment for migrants lagging in Australia
• COVID-19 public health campaign to stop misinformation

2019 (8)

• Paul Ramsay Foundation funding to tackle disadvantage
• 25 ways we're working to eliminate HIV
• First national hepatitis report reveals progress
• Primary healthcare effort needed to achieve hep C elimination
• Later HIV diagnoses for women
• Condom use not linked with STI increase among men using PrEP
• Burnet’s innovative research receives fast-track funding
• Burnet at Midsumma

2018 (10)

• A Fenner Award first
• World AIDS Day 2018: Everybody Counts
• HIV self-test approval an important step forward
• Shirley supports Burnet HIV research in memory of her son
• Preventing and responding to opioid overdose in Victoria
• New insights into PrEP, STIs, condom use
• Burnet at AIDS 2018!
• Melbourne a Fast-Track model for HIV prevention
• PrEP PBS listing expedited
• PBS listing for PrEP welcomed

2017 (9)

• U=U addressing HIV stigma
• Testing, prevention needed to reduce HIV incidence
• Burnet welcomes trial of safe injecting facility
• Saving Lives and SIF: Aaron’s story
• Burnet researchers share in NHMRC grants
• HIV research optimism on PrEP
• Burnet modelling targets HIV transmissions
• The case for new hepatitis C treatments
• New funding boost to eliminate HIV in Victoria

2016 (12)

• HIV self-testing a priority
• Burnet welcomes PrEPX regional expansion
• Hep C: Elimination is the Goal
• What next for Truvada, PrEP?
• Burnet evaluation survey of HIV prevention campaigns
• Big positives in HIV self-test kits
• NHMRC grant to assist hepatitis C research
• PrEP drug approval welcomed
• Call for AOD spending boost
• Burnet supports expanded PrEP study
• PRONTO! expansion welcomed
• Is Myanmar ready for PrEP?

2015 (10)

• 2015 in Review: July - December
• New horizons for PRONTO!
• Burnet support for HIV initiative
• Leadership needed on prison needle and syringe programs
• CREIDU Colloquium 2015: Five minute talk can save a life
• Report reveals HIV transmission in Australia declining
• PRONTO! funding welcomed
• Research key to fight against HIV
• Myanmar prepares for PrEP
• PRONTO! a Midsumma success

2014 (8)

• WAD2014: Getting to Zero - is it possible?
• AIDS fight continues
• Burnet Institute researchers acknowledged in NHMRC funding round
• Living Positive Award for Burnet
• 1000th rapid HIV test at PRONTO!
• Special HIV edition of IMPACT out now!
• STI and BBV prevention gets multi-million dollar boost
• Midsumma Carnival attracts 90,000

2013 (11)

• 2013: Year in Review
• Victorian Government creates Justice Health Advisory Council
• Centre for International Health receives first-ever NHMRC grant
• Congratulations to Burnet's NHMRC grant recipients
• Rapid HIV test clinic open for business
• Burnet to collaborate on ground-breaking PrEP trial
• Outstanding HIV researcher awarded Gust-McKenzie medal
• Leading international HIV researcher, Professor Kenneth Mayer presents at Burnet
• Dr Mark Stoové joins gay and lesbian advisory committee
• Injecting drugs: important issues and urgent responses required.
• Victoria first to trial rapid HIV test

2012 (3)

• Urgent need for HIV services in Tanzania
• Suboxone® in Australia: focus of CREIDU Colloquium
• Burnet's scientists join world leaders at AIDS 2012 Conference

2011 (4)

• Future of HIV testing in Australia
• Academy Award winner to star in Burnet sexual health promotion project
• Burnet NHMRC grant recipients 2012
• Rapid HIV testing not far away